|
31 Companies |
|
24 Products |
|
24 Products |
|
24 Mechanisms of Action |
|
0 Trials |
|
748 News |
|
| «12...3456789101112131415» |
- Enrollment change, Trial withdrawal, Trial primary completion date: Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide (clinicaltrials.gov) - Aug 15, 2014
P=N/A, N=0, Withdrawn, Sponsor: Beth Israel Deaconess Medical Center
N=22 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Sep 2015 --> Aug 2014
- Intubation: HIGHER: High Flow Nasal Canula Oxygen Helps Preoxygenate ARDS Patients (clinicaltrials.gov) - Aug 12, 2014
P=N/A, N=45, Recruiting, Sponsor: H
- Trial completion: Cord Blood 25(oh)-Vitamin D Level in Preterm Infants and Associated Morbidities (clinicaltrials.gov) - Aug 12, 2014
P=N/A, N=81, Completed, Sponsor: Dr. Sami Ulus Children's Hospital
N=22 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Sep 2015 --> Aug 2014 Recruiting --> Completed
- Aerosurf (lucinactant) / Windtree Therap, Dompe, Esteve, Lee's Pharm
Trial primary completion date: Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates (clinicaltrials.gov) - Aug 11, 2014
P2, N=42, Recruiting, Sponsor: Discovery Laboratories, Inc.
Recruiting --> Completed Trial primary completion date: Jun 2014 --> Nov 2014
- Enrollment change, Trial primary completion date: Muscle Ultrasound Signifies Condition Upgrade Leading Approach to Recovery (clinicaltrials.gov) - Aug 11, 2014
P=N/A, N=30, Recruiting, Sponsor: Wake Forest School of Medicine
Trial primary completion date: Jun 2014 --> Nov 2014 N=100 --> 30 | Trial primary completion date: Dec 2014 --> Jun 2015
- Trial termination: Intensive Nutrition in Acute Respiratory Distress Syndrome (ARDS): A Clinical Trial (INTACT) (clinicaltrials.gov) - Aug 6, 2014
P=N/A, N=78, Terminated, Sponsor: University of Illinois at Chicago
N=100 --> 30 | Trial primary completion date: Dec 2014 --> Jun 2015 Completed --> Terminated; greater mortality in intervention group
- New P1 trial: Seattle-PAP Bubble Nasal CPAP and Work of Breathing (clinicaltrials.gov) - Aug 6, 2014
P1, N=40, Recruiting, Sponsor: Seattle Children's Hospital
- ||| Enrollment open, Trial initiation date, Trial primary completion date: Does Cricoid Pressure Reduce the Risk of Aspiration? (clinicaltrials.gov) - Aug 4, 2014
P=N/A, N=450, Recruiting, Sponsor: Mayo Clinic
Completed --> Terminated; greater mortality in intervention group Not yet recruiting --> Recruiting | Initiation date: Jan 2015 --> Aug 2014 | Trial primary completion date: Jun 2016 --> Jan 2015
- ||| Enrollment open: RINO: Impact of Nasal High-flow vs Venturi Mask Oxygen Therapy on Weaning Outcome: a Multicenter, Randomized, Controlled Trial (clinicaltrials.gov) - Aug 1, 2014
P=N/A, N=500, Recruiting, Sponsor: Catholic University of the Sacred Heart
Not yet recruiting --> Recruiting | Initiation date: Jan 2015 --> Aug 2014 | Trial primary completion date: Jun 2016 --> Jan 2015 Not yet recruiting --> Recruiting
- Clinical: Effects of Chest Wall Elastance on Pulmonary Mechanics of Acute Respiratory Failure (ARF) (clinicaltrials.gov) - Jul 23, 2014
P=N/A, N=12, Not yet recruiting, Sponsor: Southeast University, China
- Trial completion, Intubation: Observational Study Evaluating the Use of Intellivent (clinicaltrials.gov) - Jul 23, 2014
P=N/A, N=100, Completed, Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Not yet recruiting --> Recruiting Recruiting --> Completed
- New P2 trial: Anti-MERS-CoV Convalescent Plasma Therapy (clinicaltrials.gov) - Jul 15, 2014
P2, N=20, Not yet recruiting, Sponsor: King Abdullah International Medical Research Center
- Review: T3: Retrospective Review of Mechanically Ventilated Patients Using a Continuous Data Collection System. (clinicaltrials.gov) - Jul 10, 2014
P=N/A, N=50, Active, not recruiting, Sponsor: Children's Hospital Boston
- Biomarker, Trial primary completion date: Impact of Inflammation Biomarkers on the Acute Respiratory Distress Syndrome (ARDS) Definition (clinicaltrials.gov) - Jul 8, 2014
P=N/A, N=134, Completed, Sponsor: University Hospital, Clermont-Ferrand
Recruiting --> Completed Trial primary completion date: Jul 2011 --> Nov 2011
- Biomarker, Enrollment change: Impact of Inflammation Biomarkers on the Acute Respiratory Distress Syndrome (ARDS) Definition (clinicaltrials.gov) - Jul 8, 2014
P=N/A, N=134, Completed, Sponsor: University Hospital, Clermont-Ferrand
Trial primary completion date: Jul 2011 --> Nov 2011 N=300 --> 134
- Biomarker, Trial completion, Enrollment change, Trial primary completion date: Impact of Inflammation Biomarkers on the Acute Respiratory Distress Syndrome (ARDS) Definition (clinicaltrials.gov) - Jul 8, 2014
P=N/A, N=134, Completed, Sponsor: University Hospital, Clermont-Ferrand
N=300 --> 134 Recruiting --> Completed | N=300 --> 134 | Trial primary completion date: Jul 2011 --> Nov 2011
- || Trial primary completion date: LIPS-B: Lung Injury Prevention Study With Budesonide and Beta (clinicaltrials.gov) - Jul 1, 2014
P2, N=60, Recruiting, Sponsor: Mayo Clinic
Recruiting --> Completed | N=300 --> 134 | Trial primary completion date: Jul 2011 --> Nov 2011 Trial primary completion date: Sep 2014 --> Jan 2015
- | New P4 trial, Compliance: APT: Standard Treatment Compliance of Participants, Effectiveness and Prognosis in Acute Respiratory Distress Syndrome (clinicaltrials.gov) - Jul 1, 2014
P4, N=120, Recruiting, Sponsor: Southeast University, China
- Trial primary completion date: Clinical and Biological Markers in Acute Respiratory Failure (clinicaltrials.gov) - Jun 27, 2014
P=N/A, N=50, Recruiting, Sponsor: University of Athens
Trial primary completion date: Sep 2014 --> Jan 2015 Trial primary completion date: Jun 2014 --> Sep 2014
- Trial primary completion date: Hyper2S: Hyperoxia and Hypertonic Saline in Septic Shock (clinicaltrials.gov) - Jun 19, 2014
P=N/A, N=441, Active, not recruiting, Sponsor: University Hospital, Angers
Trial primary completion date: Jun 2014 --> Sep 2014 Trial primary completion date: Nov 2015 --> Jun 2014
- Enrollment change: Hyper2S: Hyperoxia and Hypertonic Saline in Septic Shock (clinicaltrials.gov) - Jun 19, 2014
P=N/A, N=441, Active, not recruiting, Sponsor: University Hospital, Angers
Trial primary completion date: Nov 2015 --> Jun 2014 N=800 --> 441
- Clinical: APRiCE: Trial of an Alternate Mode of Providing Artificial Breaths to Children With Very Severe Pneumonia (clinicaltrials.gov) - Jun 19, 2014
P=N/A, N=100, Recruiting, Sponsor: Postgraduate Institute of Medical Education and Research
- sevoflurane / Generic mfg.
New P4 trial: Effects of SEvoflurane on Gas Exchange and Inflammation in Patients With ARDS (SEGA Study) (clinicaltrials.gov) - Jun 19, 2014
P4, N=50, Recruiting, Sponsor: University Hospital, Clermont-Ferrand
- Enrollment open, Stroma: Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START) (clinicaltrials.gov) - Jun 19, 2014
P2, N=60, Recruiting, Sponsor: Michael A. Matthay
N=800 --> 441 Not yet recruiting --> Recruiting
- Enrollment closed, Enrollment change, Trial primary completion date: Hyper2S: Hyperoxia and Hypertonic Saline in Septic Shock (clinicaltrials.gov) - Jun 19, 2014
P=N/A, N=441, Active, not recruiting, Sponsor: University Hospital, Angers
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting | N=800 --> 441 | Trial primary completion date: Nov 2015 --> Jun 2014
- Enrollment closed, HEOR: ALTOS: Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials (clinicaltrials.gov) - Jun 19, 2014
P=N/A, N=900, Active, not recruiting, Sponsor: Johns Hopkins University
Recruiting --> Active, not recruiting | N=800 --> 441 | Trial primary completion date: Nov 2015 --> Jun 2014 Recruiting --> Active, not recruiting
- Trial termination: Flow-flow ECCO2-R and 4 ml/kg Tidal Volume vs. 6 ml/kg Tidal Volume to Enhance Protection From VILI in Acute Lung Injury (clinicaltrials.gov) - Jun 18, 2014
P3, N=230, Terminated, Sponsor: University of Turin, Italy
Recruiting --> Active, not recruiting Recruiting --> Terminated; Financial hardship
- Enrollment open: Feasibility of Upright Bed Position in ARDS Patients (clinicaltrials.gov) - Jun 5, 2014
P=N/A, N=10, Recruiting, Sponsor: Wake Forest School of Medicine
Recruiting --> Terminated; Financial hardship Not yet recruiting --> Recruiting
- Enrollment change: Feasibility of Mid-frequency Ventilation in Newborns With RDS: Randomized Crossover Pilot Trial (clinicaltrials.gov) - May 28, 2014
P1/2, N=12, Completed, Sponsor: University of Alabama at Birmingham
Not yet recruiting --> Recruiting N=20 --> 12
- Trial completion: Feasibility of Mid-frequency Ventilation in Newborns With RDS: Randomized Crossover Pilot Trial (clinicaltrials.gov) - May 28, 2014
P1/2, N=12, Completed, Sponsor: University of Alabama at Birmingham
N=20 --> 12 Active, not recruiting --> Completed
- Clinical: Feasibility of Upright Bed Position in ARDS Patients (clinicaltrials.gov) - May 26, 2014
P=N/A, N=10, Recruiting, Sponsor: Wake Forest School of Medicine
- ticagrelor / Generic mfg.
Trial primary completion date: XANTHIPPE: Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor (clinicaltrials.gov) - May 20, 2014
P1, N=100, Recruiting, Sponsor: University of Kentucky
Active, not recruiting --> Completed Trial primary completion date: Jun 2014 --> Dec 2014
- Clinical: Electrical Activity of Diaphragm as a Means to Predict Extubation Success in Preterm Infants (clinicaltrials.gov) - May 20, 2014
P=N/A, N=40, Not yet recruiting, Sponsor: Dartmouth-Hitchcock Medical Center
- Trial primary completion date: PARSA: Pulmonary And Renal Support During Acute Respiratory Distress Syndrome (clinicaltrials.gov) - May 17, 2014
P3, N=10, Recruiting, Sponsor: H
Trial primary completion date: Jun 2014 --> Dec 2014 Trial primary completion date: Jun 2013 --> Nov 2014
- Trial completion date: PARSA: Pulmonary And Renal Support During Acute Respiratory Distress Syndrome (clinicaltrials.gov) - May 17, 2014
P3, N=10, Recruiting, Sponsor: H
Trial primary completion date: Jun 2013 --> Nov 2014 Trial completion date: Oct 2013 --> Apr 2015
- Trial primary completion date: Clinical Effect of the Association of Noninvasive Ventilation and High Flow Nasal Oxygen Therapy in Resuscitation of Patients With Acute Lung Injury (FLORALI Study) (clinicaltrials.gov) - May 11, 2014
P2/3, N=314, Completed, Sponsor: Poitiers University Hospital
Trial completion date: Oct 2013 --> Apr 2015 Trial primary completion date: Mar 2013 --> Jul 2013
- Trial completion date: Clinical Effect of the Association of Noninvasive Ventilation and High Flow Nasal Oxygen Therapy in Resuscitation of Patients With Acute Lung Injury (FLORALI Study) (clinicaltrials.gov) - May 11, 2014
P2/3, N=314, Completed, Sponsor: Poitiers University Hospital
Trial primary completion date: Mar 2013 --> Jul 2013 Trial completion date: May 2013 --> Jul 2013
- | Trial completion: Clinical Effect of the Association of Noninvasive Ventilation and High Flow Nasal Oxygen Therapy in Resuscitation of Patients With Acute Lung Injury (FLORALI Study) (clinicaltrials.gov) - May 11, 2014
P2/3, N=314, Completed, Sponsor: Poitiers University Hospital
Trial completion date: May 2013 --> Jul 2013 Recruiting --> Completed
- Trial primary completion date: Do-It-Now: Treatment of Critical Illness Polyneuromyopathy (clinicaltrials.gov) - May 6, 2014
P2, N=120, Recruiting, Sponsor: University of Colorado, Denver
Recruiting --> Completed Trial primary completion date: Apr 2014 --> May 2014
- Trial withdrawal: Pre Hospital Evaluation of Video Laryngoscopy (clinicaltrials.gov) - May 6, 2014
P4, N=0, Withdrawn, Sponsor: Assistance Publique - H
Trial primary completion date: Apr 2014 --> May 2014 Recruiting --> Withdrawn
- Enrollment change: Pre Hospital Evaluation of Video Laryngoscopy (clinicaltrials.gov) - May 6, 2014
P4, N=0, Withdrawn, Sponsor: Assistance Publique - H
Recruiting --> Withdrawn N=262 --> 0
- dexmedetomidine / Generic mfg.
Clinical: Testing the Feasibility of Patient Controlled Sedation for Ventilated ICU Patients (clinicaltrials.gov) - Apr 29, 2014
P1/2, N=40, Recruiting, Sponsor: University of Minnesota - Clinical and Translational Science Institute
N=262 --> 0 Not yet recruiting --> Recruiting
- Biomarker, Trial termination: Predicting Lung Injury From Transfusion in Patients With Liver Disease (clinicaltrials.gov) - Apr 27, 2014
P=N/A, N=16, Terminated, Sponsor: University of Colorado, Denver
Not yet recruiting --> Recruiting Recruiting --> Terminated; Recruitment
- Biomarker, Enrollment change: Predicting Lung Injury From Transfusion in Patients With Liver Disease (clinicaltrials.gov) - Apr 27, 2014
P=N/A, N=16, Terminated, Sponsor: University of Colorado, Denver
Recruiting --> Terminated; Recruitment N=120 --> 16
- Trial completion: ELASTANCE: Prospective Physiological Study of Lung Elastance in Recruitment and Derecruitment in Early Onset Mechanically Ventilated ARDS Patients (clinicaltrials.gov) - Apr 15, 2014
P3, N=12, Completed, Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
N=120 --> 16 Recruiting --> Completed
- Trial primary completion date: Intensive Nutrition in Acute Respiratory Distress Syndrome (ARDS): A Clinical Trial (INTACT) (clinicaltrials.gov) - Apr 14, 2014
P=N/A, N=78, Completed, Sponsor: University of Illinois at Chicago
Recruiting --> Completed Trial primary completion date: Jan 2014 --> Jun 2013
- Trial completion date: Intensive Nutrition in Acute Respiratory Distress Syndrome (ARDS): A Clinical Trial (INTACT) (clinicaltrials.gov) - Apr 14, 2014
P=N/A, N=78, Completed, Sponsor: University of Illinois at Chicago
Trial primary completion date: Jan 2014 --> Jun 2013 Trial completion date: Jun 2014 --> Jun 2013
- Enrollment change: Intensive Nutrition in Acute Respiratory Distress Syndrome (ARDS): A Clinical Trial (INTACT) (clinicaltrials.gov) - Apr 14, 2014
P=N/A, N=78, Completed, Sponsor: University of Illinois at Chicago
Trial completion date: Jun 2014 --> Jun 2013 N=200 --> 78
- Trial completion: Intensive Nutrition in Acute Respiratory Distress Syndrome (ARDS): A Clinical Trial (INTACT) (clinicaltrials.gov) - Apr 14, 2014
P=N/A, N=78, Completed, Sponsor: University of Illinois at Chicago
N=200 --> 78 Recruiting --> Completed
- ||||| H.P. Acthar Gel (repository corticotropin injection) / Mallinckrodt
New P2 trial: Safety and Efficacy Study of Acthar in Subjects With ARDS (clinicaltrials.gov) - Apr 13, 2014
P2, N=210, Not yet recruiting, Sponsor: Questcor Pharmaceuticals, Inc.